首页> 美国卫生研究院文献>other >COMPARISON OF RECIST (RESPONSE EVALUATION CRITERIA IN SOLID TUMORS) WITH VOLUMETRIC MEASUREMENTS FOR ESTIMATION OF TUMOR BURDEN IN PANCREATIC ADENOCARCINOMA AND HEPATOCELLULAR CARCINOMA
【2h】

COMPARISON OF RECIST (RESPONSE EVALUATION CRITERIA IN SOLID TUMORS) WITH VOLUMETRIC MEASUREMENTS FOR ESTIMATION OF TUMOR BURDEN IN PANCREATIC ADENOCARCINOMA AND HEPATOCELLULAR CARCINOMA

机译:复制(响应评价标准在实体肿瘤中的响应评价标准)对胰腺癌和肝细胞癌肿瘤负荷估算的体积测量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundRECIST (Response Evaluation Criteria in Solid Tumors) is the accepted method for determining tumor progression. However, RECIST may not accurately estimate disease burden because the axial plane often does not produce the actual longest diameter. Volumetric measurements may be an alternative to better determine tumor size. Our aim was to compare volumetric measurements with RECIST in pancreatic ductal adenocarcinomas (PDA) and hepatocellular carcinomas (HCC).
机译:BackgroundRECIST(实体瘤的反应评估标准)是确定肿瘤进展的公认方法。但是,RECIST可能无法准确估算疾病负担,因为轴向平面通常不会产生实际最长的直径。体积测量可能是更好地确定肿瘤大小的替代方法。我们的目的是比较RECIST在胰腺导管腺癌(PDA)和肝细胞癌(HCC)中的体积测量结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号